Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PAIP1 is an RNA-binding protein that acts as a coactivator for translation initiation of poly(A)-containing mRNAs by interacting with poly(A)-binding protein (PABP) and the cap-binding complex eIF4A[1][6]. It competes with PAIP2 for binding to PABPC1 and forms multiprotein complexes that help stabilize the closed-loop mRNA structure, which is crucial for efficient translation[2][4][6]. PAIP1 also interacts with multiple translation initiation factors, including eIF3 and eIF4G, and regulates protein biosynthesis and mRNA turnover[2][4][6]. In Drosophila and mammalian cells, loss or knockdown of PAIP1 leads to impaired translation, apoptosis, and activation of the integrated stress response[3]. PAIP1 has been implicated in viral protein synthesis, particularly in the context of SARS-CoV infection[6]. Its role in translation termination and readthrough at premature stop codons has also been documented, mainly through interaction with release factors and stabilization of post-termination complexes[4]. There are multiple isoforms of PAIP1 produced through alternative splicing[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyadenylate-binding protein-interacting protein 1 (PAIP1).